Mednow Inc Stock Performance
| MDNWF Stock | USD 0.02 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Mednow are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Mednow Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Mednow is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 28.8 M | |
| Total Cashflows From Investing Activities | -8 M |
Mednow |
Mednow Relative Risk vs. Return Landscape
If you would invest 2.00 in Mednow Inc on November 3, 2024 and sell it today you would earn a total of 0.00 from holding Mednow Inc or generate 0.0% return on investment over 90 days. Mednow Inc is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Mednow, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Mednow Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mednow's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Mednow Inc, and traders can use it to determine the average amount a Mednow's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MDNWF |
Based on monthly moving average Mednow is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mednow by adding Mednow to a well-diversified portfolio.
Mednow Fundamentals Growth
Mednow Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Mednow, and Mednow fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mednow Pink Sheet performance.
| Return On Equity | -1.9 | |||
| Return On Asset | -0.55 | |||
| Profit Margin | (1.14) % | |||
| Operating Margin | (0.82) % | |||
| Current Valuation | 4.96 M | |||
| Shares Outstanding | 21.57 M | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 0.18 X | |||
| Revenue | 16.64 M | |||
| EBITDA | (28.12 M) | |||
| Cash And Equivalents | 9.39 M | |||
| Cash Per Share | 0.44 X | |||
| Total Debt | 30 K | |||
| Debt To Equity | 0.28 % | |||
| Book Value Per Share | 0.09 X | |||
| Cash Flow From Operations | (16.09 M) | |||
| Earnings Per Share | (0.71) X | |||
| Total Asset | 18.13 M | |||
About Mednow Performance
By analyzing Mednow's fundamental ratios, stakeholders can gain valuable insights into Mednow's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mednow has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mednow has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. Mednow is traded on OTC Exchange in the United States.Things to note about Mednow Inc performance evaluation
Checking the ongoing alerts about Mednow for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Mednow Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mednow Inc generated a negative expected return over the last 90 days | |
| Mednow Inc has some characteristics of a very speculative penny stock | |
| Mednow Inc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 16.64 M. Net Loss for the year was (29.56 M) with profit before overhead, payroll, taxes, and interest of 2.78 M. | |
| Mednow Inc has accumulated about 9.39 M in cash with (16.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 48.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Mednow's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mednow's stock is overvalued or undervalued compared to its peers.
- Examining Mednow's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mednow's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mednow's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mednow's pink sheet. These opinions can provide insight into Mednow's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mednow Pink Sheet analysis
When running Mednow's price analysis, check to measure Mednow's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednow is operating at the current time. Most of Mednow's value examination focuses on studying past and present price action to predict the probability of Mednow's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednow's price. Additionally, you may evaluate how the addition of Mednow to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |